Healthcare | May 17, 2024
Glenmark launches next phase of ‘India First Heart First’ campaign
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
The product is used to treat amyotrophic lateral sclerosis
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels
Education on Inhalation Therapy & Conducting Nationwide Awareness Camps, Alkem Breathe Initiative Addresses the Alarming Increase in Respiratory Diseases in India
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Subscribe To Our Newsletter & Stay Updated
